Biocon Limited has announced a board meeting to seek shareholder approval via postal ballot for increasing its authorised share capital from Rs. 625 Cr to Rs. 700 Cr by adding 15 crore equity shares of Rs. 5 each. It also plans to raise up to Rs. 4,500 Cr through equity shares and/or other securities via qualified institutions placement, rights issue, preferential allotment, or private placement. The funds will support debt repayment, financial commitments of Biocon and its subsidiary Biocon Biologics, and general corporate purposes. Voting will be electronic through KFin Technologies.